Contact Us: 01282 426380
KM Financial Solutions | Amgen cuts price of cholesterol drug Repatha by 60 percent
33412
post-template-default,single,single-post,postid-33412,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Amgen cuts price of cholesterol drug Repatha by 60 percent

23 Oct Amgen cuts price of cholesterol drug Repatha by 60 percent

Posted at 20:06h in News by
0 Likes
Amgen Inc, looking to boost use
of its potent cholesterol drug Repatha, has cut the medication’s
U.S. list price by 60 percent to $5,850, the U.S. biotechnology
company said on Wednesday.

No Comments

Sorry, the comment form is closed at this time.